title: New treatments for human papillomavirus infection.
abstract: Human papillomavirus infection is very common. In this article, we review the latest developments in the treatment of lesions caused by this virus, with a particular focus on anogenital warts. Sinecatechins and new imiquimod formulations are among the most significant new developments. Others include photodynamic therapy and intralesional immunotherapy, but there is insufficient evidence to recommend their routine use. Finally, while therapeutic vaccines and inhibitory molecules appear to hold great promise, they are still in the early phases of investigation. More studies are needed, and these should have similar designs, larger samples, and sufficiently long follow-up periods to enable the direct comparison of the short-term and long-term effectiveness of different treatment options.
authors.affiliation: Servicio de Dermatología, Hospital Clínic, Universitat de Barcelona, Barcelona, España. Electronic address: carlosmunozsantos@gmail.com.
authors.forename: C
authors.initials: C
authors.lastname: Muñoz-Santos
authors.forename: R
authors.initials: R
authors.lastname: Pigem
authors.forename: M
authors.initials: M
authors.lastname: Alsina
mesh_terms: D006801:Humans; D030361:Papillomavirus Infections / Q000188:drug therapy* / Q000517:prevention & control
keywords: Condilomas acuminados; Genital Warts, Sinecatechins; Human papillomavirus; Imiquimod; Sinecatequinas; Vaccines; Vacunas; Verrugas; Virus del papiloma humano; Warts